Salarius Pharmaceuticals Net Income
| SLRXDelisted Stock | USD 0.82 0.05 6.49% |
As of the 10th of February, Salarius Pharmaceuticals has the Variance of 108.86, coefficient of variation of (543.26), and Risk Adjusted Performance of (0.14). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Salarius Pharmaceuticals, as well as the relationship between them.
Salarius Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Salarius Pharmaceuticals' valuation are provided below:Salarius Pharmaceuticals does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Salarius |
Search Suggestions
| SL | Sanlorenzo SpA Ordinary | CompanyDelisted |
| SLMBP | SLM Corp Pb | Company |
| SLB | Schlumberger NV | Company |
| SLADX | Selected American Shares | Mutual Fund |
| SLT | Pacer Financial | ETF |
| SLS | SLS | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Salarius Pharmaceuticals reported net income of (5.58 Million). This is 101.63% lower than that of the Biotechnology sector and 107.96% lower than that of the Health Care industry. The net income for all United States stocks is 100.98% higher than that of the company.
Salarius Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Salarius Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Salarius Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Salarius Pharmaceuticals by comparing valuation metrics of similar companies.Salarius Pharmaceuticals is currently under evaluation in net income category among its peers.
Salarius Fundamentals
| Return On Equity | -1.4 | |||
| Return On Asset | -0.7 | |||
| Current Valuation | 2.12 M | |||
| Shares Outstanding | 5.86 M | |||
| Shares Owned By Insiders | 0.63 % | |||
| Shares Owned By Institutions | 5.21 % | |||
| Number Of Shares Shorted | 184.64 K | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 18.12 X | |||
| Gross Profit | (15.84 M) | |||
| EBITDA | (5.73 M) | |||
| Net Income | (5.58 M) | |||
| Cash And Equivalents | 22.65 M | |||
| Cash Per Share | 10.09 X | |||
| Total Debt | 221.87 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 8.31 X | |||
| Book Value Per Share | 4.50 X | |||
| Cash Flow From Operations | (4.53 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (24.24) X | |||
| Target Price | 26.0 | |||
| Beta | 0.32 | |||
| Market Capitalization | 3.81 M | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (81.92 M) | |||
| Working Capital | 1.48 M | |||
| Current Liabilities | 1.97 M | |||
| Net Asset | 3.02 M |
About Salarius Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Salarius Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Salarius Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Salarius Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Salarius Stock
If you are still planning to invest in Salarius Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Salarius Pharmaceuticals' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |